The Patent Finder
US

Selective Serotonin 2A/2C Receptor Inverse Agonists as Therapeutics for Neurodegenerative Diseases

US 8,377,959 Term ended
OverviewFamilyAssignmentsSources & methods

Term ended Jan 15, 2024 · High confidence

USPTO later recorded it as expired for non-payment on Mar 24, 2025.

Filed Jun 29, 2012 as application 13/539,011 · Granted Feb 19, 2013
Base term, 20 years from filing
Today
20 years from filing
Term ended Jan 15, 2024
2004 2026
Clock starts
Jan 15, 2004
Term ended
Jan 15, 2024
Granted
Feb 19, 2013
base term after the term ends fee events Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
2 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
14
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Jan 15, 2004, when application 10/759,561, the earliest non-provisional in its chain, was filed (this one was filed Jun 29, 2012)Jan 15, 2024High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events2 of 2 maintenance fees paidterm endedHigh confidence
USPTO status recordRecorded as expired for non-payment on Mar 24, 2025, after the term endedno changeHigh confidence
Computed term endThe steps above, in orderJan 15, 2024High confidence

This family

US 7,601,740In force
Jan 2031
Jan 2031
US 7,732,462In force
Dec 2026
Dec 2026
US 7,994,193Term ended
Jan 2024
Jan 2024
US 8,227,487Term ended
Jan 2024
Jan 2024
US 8,377,959this patent
Jan 2024
Jan 2024
US 8,618,130Term ended
no later than Jan 2024
no later than Jan 2024
US 8,921,393Term ended
no later than Jan 2024
no later than Jan 2024
US 9,211,289Term ended
Jan 2024
Jan 2024
8 of 14 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Nov 14, 2013
Reel 31603, frame 441
Weiner, David M.; Davis, Robert E.; Brann, Mark R.Acadia Pharmaceuticals Inc.Assignment of Assignor's Interest
Nov 30, 2021
Reel 58945, frame 485
Acadia Pharmaceuticals Inc.Acadia Pharmaceuticals Inc.Assignee Change of Address

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited